Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy

Background: To investigate the diagnostic level of cystatin C and growth arrest-specific gene 6 (Gas6) levels in elderly type 2 diabetic patients with different degrees of diabetic nephropathy (DN). Methods: Four hundred and eighty-two old people, including 130 healthy controls, 130 normoalbuminuric...

Full description

Bibliographic Details
Main Authors: Wenni Li, Junlin Wang, Lina Ge, Jiehui Shan, Chunbing Zhang, Jianping Liu
Format: Article
Language:English
Published: Taylor & Francis Group 2017-05-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2017.1288739
_version_ 1797681519037251584
author Wenni Li
Junlin Wang
Lina Ge
Jiehui Shan
Chunbing Zhang
Jianping Liu
author_facet Wenni Li
Junlin Wang
Lina Ge
Jiehui Shan
Chunbing Zhang
Jianping Liu
author_sort Wenni Li
collection DOAJ
description Background: To investigate the diagnostic level of cystatin C and growth arrest-specific gene 6 (Gas6) levels in elderly type 2 diabetic patients with different degrees of diabetic nephropathy (DN). Methods: Four hundred and eighty-two old people, including 130 healthy controls, 130 normoalbuminuric diabetic patients, 122 with microalbuminuria, and 100 with macroalbuminuria, were recruited. Plasma Gas6 and serum cystatin C levels were measured. Results: Plasma Gas6 concentration was significantly lower in diabetic patients with microalbuminuria or macroalbuminuria, as compared with diabetic subjects with normoalbuminuria; while cystatin C was significantly higher. Gas6 was inversely correlated with BMI, WHR, and HbA1c, while cystatin C was inversely correlated with urea nitrogen and creatinine. Multivariate logistic regression analysis showed that, after adjusted for established diabetes risk factors, higher plasma Gas6 was significantly associated with a decreased risk of DN, while higher serum cystatin C was significantly associated with an increased risk. Receiver operating characteristic curve analysis showed that Gas6 was better than cystatin C as a biomarker for early diagnosis and detection of DN, with a cutoff value of 9.435 ng/mL (86.1% sensitivity and 84.6% specificity). Conclusion: Compared to cystatin C, Gas6 may be potentially a better noninvasive diagnostic biomarker for early detection of DN.
first_indexed 2024-03-11T23:46:00Z
format Article
id doaj.art-6e026b3c0a334fe2bbaef03e55fe59e1
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:46:00Z
publishDate 2017-05-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-6e026b3c0a334fe2bbaef03e55fe59e12023-09-19T09:24:45ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062017-05-0139438238710.1080/10641963.2017.12887391288739Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathyWenni Li0Junlin Wang1Lina Ge2Jiehui Shan3Chunbing Zhang4Jianping Liu5Shanghai Jiaotong UniversityShanghai Jiaotong UniversityShanghai Jiaotong UniversityShanghai Jiaotong UniversityShanghai Jiaotong UniversityShanghai Jiaotong UniversityBackground: To investigate the diagnostic level of cystatin C and growth arrest-specific gene 6 (Gas6) levels in elderly type 2 diabetic patients with different degrees of diabetic nephropathy (DN). Methods: Four hundred and eighty-two old people, including 130 healthy controls, 130 normoalbuminuric diabetic patients, 122 with microalbuminuria, and 100 with macroalbuminuria, were recruited. Plasma Gas6 and serum cystatin C levels were measured. Results: Plasma Gas6 concentration was significantly lower in diabetic patients with microalbuminuria or macroalbuminuria, as compared with diabetic subjects with normoalbuminuria; while cystatin C was significantly higher. Gas6 was inversely correlated with BMI, WHR, and HbA1c, while cystatin C was inversely correlated with urea nitrogen and creatinine. Multivariate logistic regression analysis showed that, after adjusted for established diabetes risk factors, higher plasma Gas6 was significantly associated with a decreased risk of DN, while higher serum cystatin C was significantly associated with an increased risk. Receiver operating characteristic curve analysis showed that Gas6 was better than cystatin C as a biomarker for early diagnosis and detection of DN, with a cutoff value of 9.435 ng/mL (86.1% sensitivity and 84.6% specificity). Conclusion: Compared to cystatin C, Gas6 may be potentially a better noninvasive diagnostic biomarker for early detection of DN.http://dx.doi.org/10.1080/10641963.2017.1288739biomarkercystatin cdiabetic nephropathy (dn)early detectiongrowth arrest-specific gene 6 (gas6)
spellingShingle Wenni Li
Junlin Wang
Lina Ge
Jiehui Shan
Chunbing Zhang
Jianping Liu
Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
Clinical and Experimental Hypertension
biomarker
cystatin c
diabetic nephropathy (dn)
early detection
growth arrest-specific gene 6 (gas6)
title Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
title_full Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
title_fullStr Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
title_full_unstemmed Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
title_short Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
title_sort growth arrest specific protein 6 gas6 as a noninvasive biomarker for early detection of diabetic nephropathy
topic biomarker
cystatin c
diabetic nephropathy (dn)
early detection
growth arrest-specific gene 6 (gas6)
url http://dx.doi.org/10.1080/10641963.2017.1288739
work_keys_str_mv AT wennili growtharrestspecificprotein6gas6asanoninvasivebiomarkerforearlydetectionofdiabeticnephropathy
AT junlinwang growtharrestspecificprotein6gas6asanoninvasivebiomarkerforearlydetectionofdiabeticnephropathy
AT linage growtharrestspecificprotein6gas6asanoninvasivebiomarkerforearlydetectionofdiabeticnephropathy
AT jiehuishan growtharrestspecificprotein6gas6asanoninvasivebiomarkerforearlydetectionofdiabeticnephropathy
AT chunbingzhang growtharrestspecificprotein6gas6asanoninvasivebiomarkerforearlydetectionofdiabeticnephropathy
AT jianpingliu growtharrestspecificprotein6gas6asanoninvasivebiomarkerforearlydetectionofdiabeticnephropathy